Verified facts
GSK reported quarterly turnover of £8.887bn, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit was £2.127bn, down 18% at actual rates.
Core operating profit was £3.076bn, up 3% at actual rates. The company cited restructuring charges and other operating-income changes in explaining the difference between core and total performance. It declared a 17p quarterly dividend.
Apolifina analysis
The core result is an alternative performance measure, not a substitute for total profit. Currency adjustment also changes the comparison. Investors need both the reported result and the reconciliation rather than treating one adjusted growth rate as the whole business outcome.
Uncertainty and risk
Future guidance and dividends are not guarantees. Product demand, research spending and regulation create risk. This financial article does not offer medical advice or imply approval of any medicine beyond its authorised indication. General information only.
Primary sources
Source released 28 October 2026. Published 28 October 2026.
Continue reading: Newsroom · Related coverage